series-a
Stage
2020
Founded
1
Investors
About
Orbis Medicines is a biotechnology company focused on the discovery and development of oral macrocycle drugs. It utilizes its AI-powered nGen platform to systematically explore macrocycle chemical space, aiming to create orally bioavailable alternatives to injectable biologic drugs for various therapeutic areas.
Explore Orbis Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.